News Archive

Bonum Therapeutics Announces a $93M Series A Financing to Advance a Novel and Validated Class of Conditionally Active Therapies

“We believe that this technology has broad potential and we are excited to apply it in new areas…”

Nov 15, 2022 Press Release

The View from Business Development at Bonum Therapeutics

LinkedIn

OCT 24, 2022 Blog

Healthcare Investor Digitalis Ventures Nets $300 Million Fund

Wall Street Journal

Oct 18, 2022 Media

6 Drug Discovery Learnings From The Lab

Drug Discovery Online

OCT 5, 2022 Blog

Sequel company Bonum emerges in wake of Roche’s Good Tx acquisition

Biocentury

Sep 8, 2022 Media

Roche to pay $250M for Good Therapeutics and its targeted drug technology

Biopharmadive

Sep 7, 2022 Media

Roche Buys IL-2 Technology From Good, Which Forms New Firm Bonum

Scrip

Sep 07, 2022 Media

Good Therapeutics being acquired by Roche for $250M

The Business Journals

Sep 07, 2022 Media

Bonum to continue Good work after $250M cash acquisition deal with Roche

BioWorld

Sep 7, 2022 Media